GLUCOVANCE

This brand name is authorized in Brazil, Ecuador, France, Hong Kong SAR China, Mexico, Netherlands, Nigeria, Romania, Singapore, South Africa, Tunisia.

Active ingredients

The drug GLUCOVANCE contains a combination of these active pharmaceutical ingredients (APIs):

1	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin
2	Glibenclamide UNII SX6K58TVWC - GLYBURIDE
	Glibenclamide, a second-generation, short half-life sulphonylurea, is a hypoglycaemic agent that reduces blood-glucose by stimulating insulin release by the pancreas. Sulphonylureas act on pancreatic beta-cells by inhibiting ATP-sensitive potassium channels.
	Read more about Glibenclamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GLUCOVANCE Film-coated tablet	MPI, EU: SmPC	Web Search

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD02	Metformin and sulfonamides	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525405201114411, 525405202110411, 525405203117418, 525405207112313
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.379-1-01-12, 24.387-1-01-12
FR	Base de données publique des médicaments	63079915, 65940127, 68942820
HK	Department of Health Drug Office	50965, 50966, 50967
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	565M95
NG	Registered Drug Product Database	04-7609, 04-7702, B4-6067
Switch country to Nigeria in order to find specific presentations of GLUCOVANCE
NL	Z-Index G-Standaard, PRK	65625, 65633
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W13594001, W13594002, W13594003, W13594004, W13594006, W13595001, W13595002, W13595003, W13595004, W13595006
SG	Health Sciences Authority	12322P
TN	Direction de la Pharmacie et du Médicament	3183071, 3183072
ZA	Health Products Regulatory Authority	36/21.2/0413